Compare KMT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KMT | PRGO |
|---|---|---|
| Founded | 1938 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.0B |
| IPO Year | 1994 | 2013 |
| Metric | KMT | PRGO |
|---|---|---|
| Price | $38.20 | $9.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $36.00 | $19.33 |
| AVG Volume (30 Days) | 1.7M | ★ 3.3M |
| Earning Date | 05-06-2026 | 05-29-2026 |
| Dividend Yield | 2.06% | ★ 12.31% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $1,966,845,000.00 | $800,000.00 |
| Revenue This Year | $14.45 | N/A |
| Revenue Next Year | $7.95 | $1.02 |
| P/E Ratio | $52.42 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.30 | $9.25 |
| 52 Week High | $42.03 | $29.08 |
| Indicator | KMT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 16.27 |
| Support Level | $37.93 | N/A |
| Resistance Level | $41.89 | $14.84 |
| Average True Range (ATR) | 1.70 | 0.64 |
| MACD | -0.44 | -0.38 |
| Stochastic Oscillator | 32.99 | 0.54 |
Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.